ATE279440T1 - Wachstumshormonsekretionsförderer rezeptorfamilie - Google Patents

Wachstumshormonsekretionsförderer rezeptorfamilie

Info

Publication number
ATE279440T1
ATE279440T1 AT96945183T AT96945183T ATE279440T1 AT E279440 T1 ATE279440 T1 AT E279440T1 AT 96945183 T AT96945183 T AT 96945183T AT 96945183 T AT96945183 T AT 96945183T AT E279440 T1 ATE279440 T1 AT E279440T1
Authority
AT
Austria
Prior art keywords
growth hormone
receptors
receptor family
hormone secretion
hormone secretagogue
Prior art date
Application number
AT96945183T
Other languages
English (en)
Inventor
Joseph P Arena
Doris F Cully
Scott D Feighner
Andrew D Howard
Paul A Liberator
James M Schaeffer
Der Ploeg Leonardus Van
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE279440T1 publication Critical patent/ATE279440T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96945183T 1995-12-13 1996-12-10 Wachstumshormonsekretionsförderer rezeptorfamilie ATE279440T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US858295P 1995-12-13 1995-12-13
US1896296P 1996-06-06 1996-06-06
PCT/US1996/019445 WO1997021730A1 (en) 1995-12-13 1996-12-10 Growth hormone secretagogue receptor family

Publications (1)

Publication Number Publication Date
ATE279440T1 true ATE279440T1 (de) 2004-10-15

Family

ID=26678344

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96945183T ATE279440T1 (de) 1995-12-13 1996-12-10 Wachstumshormonsekretionsförderer rezeptorfamilie

Country Status (7)

Country Link
EP (1) EP0876402B1 (de)
JP (1) JP3754084B2 (de)
AT (1) ATE279440T1 (de)
CA (1) CA2240427C (de)
DE (1) DE69633637T2 (de)
ES (1) ES2229289T3 (de)
WO (1) WO1997021730A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2340095A1 (en) 1998-08-10 2000-02-24 Merck & Co., Inc. Canine growth hormone secretagogue receptor
CA2341649A1 (en) * 1998-09-02 2000-03-09 Merck & Co., Inc. Enhancement of return to independent living status with a growth hormone secretagogue
CA2392019A1 (en) 1999-11-22 2001-05-31 Zymogenetics, Inc. Method of forming a peptide-receptor complex with zsig33
US6897286B2 (en) 2000-05-11 2005-05-24 Zymogenetics, Inc. Zsig33-like peptides
EP1286697A2 (de) * 2000-05-17 2003-03-05 Eli Lilly And Company Methode zur selektiven hemmung der aktivität von ghrelin
EP1159964B1 (de) 2000-05-31 2009-10-28 Pfizer Products Inc. Verwendung von Wachstumshormonsekretagoga zur Förderung der Beweglichkeit des Verdauungstrakts
EP1578778B1 (de) 2002-07-23 2011-01-26 Ipsen Pharma Ghrelin-analoga
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
CN101657436A (zh) 2007-02-09 2010-02-24 特兰齐姆制药公司 大环生长素释放肽受体调节剂及其使用方法
CN102812037A (zh) 2009-10-30 2012-12-05 特兰齐姆制药公司 大环生长素释放肽受体拮抗剂和反向激动剂及其使用方法
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
US20170121385A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057417A (en) * 1987-06-12 1991-10-15 Genentech, Inc. Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein
US5583010A (en) * 1992-06-23 1996-12-10 American Cyanamid Company Nucleic acid molecule encoding the porcine growth hormone receptor

Also Published As

Publication number Publication date
CA2240427A1 (en) 1997-06-19
CA2240427C (en) 2007-08-14
EP0876402A4 (de) 2002-08-07
JPH11510706A (ja) 1999-09-21
JP3754084B2 (ja) 2006-03-08
EP0876402B1 (de) 2004-10-13
DE69633637T2 (de) 2006-03-09
ES2229289T3 (es) 2005-04-16
DE69633637D1 (de) 2004-11-18
WO1997021730A1 (en) 1997-06-19
EP0876402A1 (de) 1998-11-11

Similar Documents

Publication Publication Date Title
ATE279440T1 (de) Wachstumshormonsekretionsförderer rezeptorfamilie
RU2198182C2 (ru) Аналоги гормона паращитовидной железы
AU707094B2 (en) Analogs of parathyroid hormone
US7410948B2 (en) Analogs of parathyroid hormone
US6544949B1 (en) Analogs of parathyroid hormone
IL125711A0 (en) Human metabotropic glutamate receptor
GR3023614T3 (en) Use of human igf-i
ATE307798T1 (de) Glucagon antagonisten/inverse agonisten
US5969095A (en) Analogs of parathyroid hormone
FI990126A0 (fi) Paratyreoideahormonianalogeja osteoporoosin hoitoon
EP0277626A3 (de) Synthetische Analoge von GHRH
Andersson et al. Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity binding protein for VIP, shown to be identical to calmodulin
Boonen et al. Strategies for the prevention of senile (type II) osteoporosis: an update
CN1916025B (zh) 甲状旁腺素类似物
Gammeltoft et al. VIP receptors in hog liver cells. Degradation of bound VIP and different binding characteristics compared with other tissues

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties